Pharmacokinetics and Antitumor Efficacy of XMT-1001, a Novel, Polymeric Topoisomerase I Inhibitor, in Mice Bearing HT-29 Human Colon Carcinoma Xenografts

Overview of attention for article published in Clinical Cancer Research, April 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

patent: 1 patent

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 39 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

HDAC inhibiting derivatives of camptothecin

Grant US-8980909-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.